Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis
Allergen-specific immunotherapy has not been well-studied in the setting of increasingly common immune system-targeting medications. Subcutaneous immunotherapy may not be contraindicated in patients taking anti-CD20 mAbs antibodies and/or Janus kinase inhibitors.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Journal of Allergy and Clinical Immunology: Global |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772829325000128 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832573003853987840 |
|---|---|
| author | Twan Sia, BA Leeon Bacchus, BA Stanley Liu, BS John Leung, MD |
| author_facet | Twan Sia, BA Leeon Bacchus, BA Stanley Liu, BS John Leung, MD |
| author_sort | Twan Sia, BA |
| collection | DOAJ |
| description | Allergen-specific immunotherapy has not been well-studied in the setting of increasingly common immune system-targeting medications. Subcutaneous immunotherapy may not be contraindicated in patients taking anti-CD20 mAbs antibodies and/or Janus kinase inhibitors. |
| format | Article |
| id | doaj-art-47d324dfc234464380e8098bca5875be |
| institution | Kabale University |
| issn | 2772-8293 |
| language | English |
| publishDate | 2025-05-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Journal of Allergy and Clinical Immunology: Global |
| spelling | doaj-art-47d324dfc234464380e8098bca5875be2025-02-02T05:29:36ZengElsevierJournal of Allergy and Clinical Immunology: Global2772-82932025-05-0142100411Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitisTwan Sia, BA0Leeon Bacchus, BA1Stanley Liu, BS2John Leung, MD3Boston Specialists, Boston, Mass; Stanford University School of Medicine, Stanford, CalifBoston Specialists, Boston, MassBoston Specialists, Boston, MassBoston Specialists, Boston, Mass; Corresponding author: John Leung, MD, Boston Specialists, 75 Kneeland St, Boston, MA 02111.Allergen-specific immunotherapy has not been well-studied in the setting of increasingly common immune system-targeting medications. Subcutaneous immunotherapy may not be contraindicated in patients taking anti-CD20 mAbs antibodies and/or Janus kinase inhibitors.http://www.sciencedirect.com/science/article/pii/S2772829325000128SCITallergic rhinitisMSofatumumabupadacitinibCD20 |
| spellingShingle | Twan Sia, BA Leeon Bacchus, BA Stanley Liu, BS John Leung, MD Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis Journal of Allergy and Clinical Immunology: Global SCIT allergic rhinitis MS ofatumumab upadacitinib CD20 |
| title | Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis |
| title_full | Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis |
| title_fullStr | Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis |
| title_full_unstemmed | Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis |
| title_short | Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis |
| title_sort | subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis |
| topic | SCIT allergic rhinitis MS ofatumumab upadacitinib CD20 |
| url | http://www.sciencedirect.com/science/article/pii/S2772829325000128 |
| work_keys_str_mv | AT twansiaba subcutaneousimmunotherapyinapatienttakingofatumumabformultiplesclerosisandupadacitinibforatopicdermatitis AT leeonbacchusba subcutaneousimmunotherapyinapatienttakingofatumumabformultiplesclerosisandupadacitinibforatopicdermatitis AT stanleyliubs subcutaneousimmunotherapyinapatienttakingofatumumabformultiplesclerosisandupadacitinibforatopicdermatitis AT johnleungmd subcutaneousimmunotherapyinapatienttakingofatumumabformultiplesclerosisandupadacitinibforatopicdermatitis |